Home Page > ANTIBODY > MONOCLONAL ANTIBODY > Common Antibody >  Mouse Monoclonal anti-Human CD140b (PDGFRß) Antibody

Mouse Monoclonal anti-Human CD140b (PDGFRß) Antibody


Item#:
xAP-0106
Size Price Quantity
100.0 ug $400.00
Catalog Number xAP-0106
ID Mouse Monoclonal anti-Human CD140b (PDGFRß) Antibody
Antigen Description CD140b is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. The identity of the growth factor bound to the receptor determines whether the functional receptor is a homodimer or heterodimer composed of both PDGFR-a and -ß. CD140b contains two immunoglobulin-like domains and a tyrosine kinase domain with a predicted molecular weight approximately 124 kD. CD140b is widely expressed on a variety of mesenchymal-derived cells and is preferentially expressed on some tumors such as medulloblastoma. Binding of B-chain containing PDGF molecules can stimulate cell proliferation. CD140b has been shown to interact with a number of kinases (including Raf-1, NCK1, FAK, Fyn, others) as well as adaptor molecules and signaling intermediates (Crk, Grb2, Grb4, RasGAP, SHP2, SHC1, others), and has also been shown to associate with integrin ß3 and nexin sorting molecules. CD140b has been implicated in several disease states including atherogenesis and oncogenesis. The PDGFRß is heavily phosphorylated on numerous tyrosine residues through both autophosphorylation and ligand-dependent processes. 
Size 100ug
Immunogen NIH-3T3 cells transfected with human PDGFRbeta
Clone #18A2
Antibody Isotype Mouse IgG1
Host Species Mouse
Preparation The antibody was purified by affinity chromatography.
Formulation The IgG fraction of culture supernatant was purified by Protein G affinity chromatography and lyophilized from a 0.2 um filtered solution in phosphate-buffered saline (PBS).
Application FC
Storage & Handling Reconstitute the antibody with 200 ul sterile PBS and the final concentration is 0.5mg/ml. Reconstituted antibody can also be aliquoted and stored frozen at < -20C for at least for six months without detectable loss of activity. Avoid repeated freeze-thaw cycles.

ANGIO-PROTEOMIE, ALL RIGHTS RESERVED